CCN 451303LIMESTONE CountyGovernment - Hospital District or AuthorityRural (USDA RUCC)20 bedsLatest FY 2025
Cost-report basis
HCRIS · as filed
Not audited by Astrelis
The read
A hospital in Groesbeck, TX. It ran an operating loss of 17.7% in FY25 on $25.8M of operating revenue. It held 1,175 days of cash on hand (99th percentile among Critical Access Hospitals on liquidity). Operating margin improved from -49.6% in FY20 to -17.7% in FY25, though it fell 6.5 points in the most recent year. Including nonoperating items, the all-in result was positive at 6.5%.
Operating margin · FY25
-17.7%
▼ 6.5 pts vs FY24
vs Critical Access Hospitals14th pctl of 824 (FY25)
Days cash on hand · FY25
1,175d
all sources
▲ 32.6 days vs FY24
vs Critical Access Hospitals99th pctl of 827 (FY25)
Total operating revenue · FY25
$25.8M
▼ 0.6 $M vs FY24
vs Critical Access Hospitals39th pctl of 833 (FY25)
Total margin · incl. nonoperating · FY25
+6.5%
▲ 0.1 pts vs FY24
vs Critical Access Hospitals50th pctl of 824 (FY25)
One point of operating margin at LIMESTONE MEDICAL CENTER is about $258K per year (1% of FY25 total operating revenue).
Where LIMESTONE MEDICAL CENTER sits among Critical Access Hospitals
Operating margin · FY25 pool · n = 824 of 1,404 filed
Each point is one Critical Access Hospital in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The Critical Access Hospital median is -0.2%. Descriptive context only, not a ranking.
One critical access hospitalLIMESTONE MEDICALCritical Access Hospital median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this hospital is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
Medicare inpatient contribution margin
-9.7% (FY25)
33rd percentile of 21 CAHs. Full comparison in the CAH Performance Benchmark.
HCRIS cost report · CAH economics engine
Medicare outpatient contribution margin
+60.5% (FY25)
91st percentile of 21 CAHs. Full comparison in the CAH Performance Benchmark.
HCRIS cost report · CAH economics engine
$ in thousands
Line item
FY23
FY24
FY25
Patient revenue
20,473
26,167
25,585
Other operating revenue
128
206
216
Total operating revenue
20,601
26,373
25,801
Total operating expenses
26,617
29,318
30,361
Operating income
(6,016)
(2,945)
(4,561)
Operating margin %
-29.2%
-11.2%
-17.7%
Grants & contributions
83
128
112
Investment income
2,702
3,960
3,514
Other non-operating, net
14,159
12,362
15,687
Net income
10,928
13,505
14,752
Net income %
+29.1%
+31.5%
+32.7%
HCRIS Worksheet G-3 / S-3 · $ thousands · FY20–FY25 · FY20–21 may include COVID-era relief funding in nonoperating income
How it operates
quality & operational context · CMS public reporting
A 20-bed hospital at 6% occupancy where swing beds are 62% of the inpatient business and 93% of patient revenue is outpatient.
The metrics this hospital type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Scale and flow
Occupancy
6.5%
Verified fact2025
HCRIS WS S-3
Average daily census
1.29
Verified fact2025
HCRIS WS S-3
Staffed beds (acute)
20
Verified fact2025
HCRIS WS S-3
Annual discharges
165
Verified fact2025
HCRIS WS S-3
Average length of stay
2.9d
Verified fact2025
HCRIS WS S-3
Swing-bed average daily census
2.15
Verified fact2025
HCRIS WS S-3 L5–6
Swing-bed share of inpatient days
62.4%
Verified fact2025
HCRIS WS S-3 (acute + swing days)
Outpatient share of patient revenue
93.1%
Verified fact2025
HCRIS WS G-2 L28
Who it serves
Total unreimbursed & uncompensated care
$4.1M
Verified fact2023
HCRIS WS S-10 line 31
How the care measures up
C. difficile infection (SIR)
Results cannot be calculated for this reporting period.
CMS-reported measure07/01/2024 to 06/30/2025
CMS Care Compare
Hospital-wide unplanned readmission
14.8%
No Different Than the National Rate
CMS-reported measure07/01/2023 to 06/30/2024
CMS Care Compare
Trajectory
Cost-report basis · 6 reporting years
Operating margin
Days cash on hand
The county this hospital serves
LIMESTONE County, TX · nonmetro, urban 5–20K, metro-adjacent
Median household income
$58.1K
vs $82.1K US · $59.7K rural median
Poverty rate
19.4%
vs 12.5% US · 14.3% rural median
Uninsured
18.0%
vs 8.6% US · 8.4% rural median
Age 65+
20.7%
vs 16.8% US · 20.6% rural median
Fair or poor health
25.0%
self-reported, adults · CDC PLACES
Primary-care shortage
Designated
HRSA HPSA
Economic context: 22.0% of county personal income is Medicare/Medicaid medical benefits; 37.7% arrives as government transfers (BEA, 2022).
What this hospital means to Limestone County
economic contribution · FY25 cost report
Direct annual spending
$30.4M
total operating expense · reported
Total economic output
$69.8M
× 2.30 output multiplier · estimate, upper bound for rural
Method: NCRHW 2016 study of critical access hospitals (IMPLAN Type II), employment × 1.34, earnings × 1.19; output × 2.30 (AHA national, upper bound for rural). Direct figures are reported values from the facility's HCRIS cost report; multiplied figures are estimates.
The Board Briefing$1,000
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
Where this facility is underperforming its matched peer cohort and what that gap is worth, measure by measure. Founding Edition: delivered within 30 days of eligibility confirmation, full refund if the published scope cannot be delivered.
Commercial Pricing Study$10,000CAH only, subject to data validation
Your negotiated commercial rates against Medicare and against peers, from hospitals' own published price files. We validate your hospital's rate file before taking payment.
